SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                               __________________

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) of the
                         SECURITIES EXCHANGE ACT OF 1934

                               __________________


                          Date of Report: July 25, 2002

                          ALTRIMEGA HEALTH CORPORATION
                          ----------------------------
               (Exact Name of Registrant as Specified in Charter)


            NEVADA                   000-29057               87-0631750
            ------                   ---------               ----------
(State or other jurisdiction        (Commission            (IRS Employer
      of incorporation)             File Number)         Identification No.)

 5600 BELL STREET, SUITE 111,
       AMARILLO, TEXAS                                          79106
 ----------------------------                                   -----
(Address of principal executive                               (Zip code)
           offices)

Registrant's telephone number,                             (806) 331-6398
     including area code:                                  --------------







ITEM 7.  EXHIBITS


Exhibit 99.1   Letter of Intent,  dated July 25, 2002,  between Altrimega Health
               Corporation and Creative Holdings, Inc.

ITEM 9.  REGULATION FD DISCLOSURE

         On July 25, 2002,  Altrimega Health  Corporation,  a Nevada corporation
(the  "Company"),  entered into a  non-binding  letter of intent (the "Letter of
Intent") with Creative Holdings,  Inc., a South Carolina corporation  ("Creative
Holdings").  Pursuant  to the  Letter of Intent and upon the  consummation  of a
definitive  agreement,  Creative  Holdings will merge with and into the Company.
Upon  consummation  of the merge and an amendment to the  Company's  Articles of
Incorporation   increasing  the  authorized  common  stock  of  the  Company  to
800,000,000  shares,  Creative will receive  320,000,000 shares of the Company's
common stock.





                                       2





                                   SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                    ALTRIMEGA HEALTH CORPORATION



Date: July 25, 2002                 By: /s/ Kelley Magee
                                       -----------------------------------------
                                    Name:  Kelley Magee
                                    Its:   President and Chief Executive Officer



                                       3